Chapter
Transparency and Access to FDA Data
16:03 - 23:03 (07:00)
Should people have full transparency and immediate access to FDA data? While the FDA have their own time-consuming process, transparency might be one of their most powerful tools to inspire trust in science.
Clips
The FDA's decision to release Pfizer data 75 years later has raised questions about the need for transparency and immediate access to data, as well as the reason behind the decision.
16:03 - 18:09 (02:05)
Summary
The FDA's decision to release Pfizer data 75 years later has raised questions about the need for transparency and immediate access to data, as well as the reason behind the decision.
ChapterTransparency and Access to FDA Data
Episode#249 – Albert Bourla: Pfizer CEO
PodcastLex Fridman Podcast
The FDA has the potential to be one of the great institutions of our country, but lack of transparency in their approval process feels like a failure.
18:09 - 19:40 (01:31)
Summary
The FDA has the potential to be one of the great institutions of our country, but lack of transparency in their approval process feels like a failure. However, the review process is actually very detailed and everything discussed is released in a specifications document, which is not a black box type of process.
ChapterTransparency and Access to FDA Data
Episode#249 – Albert Bourla: Pfizer CEO
PodcastLex Fridman Podcast
The speaker believes that the scientific community should be more open-minded when it comes to implementing new technologies and that effective communication is important for the success of scientific solutions such as vaccines.
19:40 - 23:03 (03:23)
Summary
The speaker believes that the scientific community should be more open-minded when it comes to implementing new technologies and that effective communication is important for the success of scientific solutions such as vaccines. Silence can lead to division and lack of trust within the community.